# Stem Cell Therapy for Cardiac Disease Sector

Canonical URL: https://biopharmsignal.com/sector/stem-cell-therapy-for-cardiac-disease

Stem Cell Therapy for Cardiac Disease is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Stem Cell Therapy for Cardiac Disease, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.

Companies currently grouped under Stem Cell Therapy for Cardiac Disease: 2

## Recent Sector News

- 2026-07-14 11:00 EST — BEAT — [HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device](https://biopharmsignal.com/news/BEAT/heartbeam-awarded-new-u-s-patent-expanding-acoustic-sensing-and-fluid-monitoring-e0c78764) — Source: HeartBeam
- 2026-06-30 11:00 EST — BEAT — [HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule](https://biopharmsignal.com/news/BEAT/heartbeam-completes-enrollment-in-heart-attack-detection-pilot-study-ahead-of-sc-c3aedd75) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition](https://biopharmsignal.com/news/BEAT/heartbeam-announces-strategic-shift-to-accelerate-global-adoption-of-its-ambulatory-ecg-signal-platform-and-leadership-transition) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home](https://biopharmsignal.com/news/BEAT/heartbeam-announces-new-peer-reviewed-article-demonstrating-potential-to-help-identify-heart-attack-risk-at-home) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam Reports First Quarter 2026 Results](https://biopharmsignal.com/news/BEAT/heartbeam-reports-first-quarter-2026-results) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic](https://biopharmsignal.com/news/BEAT/heartbeam-initiates-pilot-study-of-first-on-demand-12-lead-ecg-patch-to-detect-ischemia-outside-the-clinic) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice](https://biopharmsignal.com/news/BEAT/heartbeam-expands-commercial-presence-across-four-key-u-s-markets-with-addition-of-premier-concierge-practice) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market](https://biopharmsignal.com/news/BEAT/heartbeam-announces-first-commercial-customer-as-clearcardio-brings-groundbreaking-12-lead-ecg-technology-to-high-growth-preventive-cardiology-market) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time](https://biopharmsignal.com/news/BEAT/heartbeam-to-host-fourth-quarter-full-year-2025-results-conference-call-on-thursday-march-12-2026-at-4-30-p-m-eastern-time) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study](https://biopharmsignal.com/news/BEAT/heartbeam-announces-first-patient-enrollments-in-heart-attack-detection-pilot-study) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch](https://biopharmsignal.com/news/BEAT/heartbeam-to-attend-investor-and-industry-conferences-in-march-focused-on-providing-updates-on-commercial-launch-and-unveiling-12-lead-ecg-extended-wear-patch) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home](https://biopharmsignal.com/news/BEAT/heartbeam-and-mount-sinai-announce-strategic-ai-collaboration-to-bring-clinical-grade-heart-monitoring-into-the-home) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam Reports Fourth Quarter and Full Year 2025 Results](https://biopharmsignal.com/news/BEAT/heartbeam-reports-fourth-quarter-and-full-year-2025-results) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam Announces Proposed Public Offering of Common Stock](https://biopharmsignal.com/news/BEAT/heartbeam-announces-proposed-public-offering-of-common-stock) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock](https://biopharmsignal.com/news/BEAT/heartbeam-announces-pricing-of-10-million-public-offering-of-common-stock) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam Announces Closing of $10 Million Public Offering of Common Stock](https://biopharmsignal.com/news/BEAT/heartbeam-announces-closing-of-10-million-public-offering-of-common-stock) — Source: HeartBeam
- 2026-06-25 13:46 EST — BEAT — [HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time](https://biopharmsignal.com/news/BEAT/heartbeam-to-host-first-quarter-2026-results-conference-call-on-wednesday-may-13-2026-at-4-30-p-m-eastern-time) — Source: HeartBeam

## Companies

- [BEAT](https://biopharmsignal.com/company/BEAT) — HeartBeam
- [HSCS](https://biopharmsignal.com/company/HSCS) — HeartSciences